Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …

Background: Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory
biomarker that is used to predict mortality, readmission, early discharge, and LOS, thus …

Background To understand and measure the association between chronic inflammation,
aging, and age-related diseases, broadly applicable standard biomarkers of systemic …

Background Low-grade inflammation may occur in association with several mental disorders
of early adulthood, though associations with markers of chronic inflammation such as …

Background Circulating levels of soluble urokinase plasminogen activation receptor
(suPAR) have been proposed as a prognostic biomarker in patients with critical illness and …

Soluble urokinase-type plasminogen activator receptor (suPAR) is a chronic inflammation
marker associated with the development of a range of diseases, including cancer and …

Emergency department (ED) overcrowding is a global issue setting challenges to all care
providers. Elderly patients are frequent visitors of the ED and their risk stratification is …

Inflammation is associated with poor physical and mental health including major depressive
disorder (MDD). Moreover, there is evidence that childhood adversity–a risk factor for MDD …

Introduction Inflammation has been associated with depression and differential
antidepressant (AD) treatment response. Soluble urokinase plasminogen activator receptor …

Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker
and risk factor for kidney diseases, with a potential prognostic value in critically ill patients. In …